Page last updated: 2024-09-04

willardiine and gyki 52466

willardiine has been researched along with gyki 52466 in 1 studies

Compound Research Comparison

Studies
(willardiine)
Trials
(willardiine)
Recent Studies (post-2010)
(willardiine)
Studies
(gyki 52466)
Trials
(gyki 52466)
Recent Studies (post-2010) (gyki 52466)
43010312038

Protein Interaction Comparison

ProteinTaxonomywillardiine (IC50)gyki 52466 (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)10
Glutamate receptor 2Rattus norvegicus (Norway rat)10
Glutamate receptor 3Rattus norvegicus (Norway rat)10
Glutamate receptor 4Rattus norvegicus (Norway rat)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, AC; Kessler, M; Lynch, G; Rogers, G1

Other Studies

1 other study(ies) available for willardiine and gyki 52466

ArticleYear
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.
    Molecular pharmacology, 2000, Volume: 58, Issue:4

    Topics: Alanine; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Cells, Cultured; Diuretics; Drug Interactions; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Humans; In Vitro Techniques; Male; Oxazines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recombinant Proteins; Sodium Chloride Symporter Inhibitors; Tritium; Uracil

2000